SCHEMBL23060381

SCHEMBL23060381

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5ccc(-c6ccc7cc(-c8c9ccccc9c(-c9ccc(-c%10cccc%11oc%12ccccc%12c%10%11)cc9)c9ccccc89)ccc7c6)c6oc7ccccc7c56)cc4)c4ccccc34)cccc2c1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.40
▸ CDC14B O60729 2/20 0.36
▸ CDC14A Q9UNH5 2/20 0.36
▸ PRKDC P78527 2/20 0.35
▸ GPR84 Q9NQS5 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ MCL1 Q07820 1/20 0.33
▸ ACMSD Q8TDX5 1/20 0.33
▸ BACE1 P56817 1/20 0.32
▸ ANPEP P15144 1/20 0.32
▸ CYP1A1 P04798 1/20 0.32
▸ CYP1B1 Q16678 1/20 0.32
▸ GGPS1 O95749 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22087407 0.94 ALOX5 (0.41) ALOX5CDC14BCDC14APRKDCGPR84
SCHEMBL22178585 0.94 ALOX5 (0.36) ALOX5CDC14BCDC14APRKDCGPR84
SCHEMBL22088897 0.92 ALOX5 (0.41) ALOX5CDC14BCDC14APRKDCGPR84
SCHEMBL22855101 0.92 ALOX5 (0.40) ALOX5CDC14BCDC14APRKDCGPR84
SCHEMBL24922915 0.91 ALOX5 (0.36) ALOX5CDC14BCDC14APRKDCGPR84
SCHEMBL22063384 0.91 TDP1 (0.39) ALOX5PRKDCGPR84TDP1L3MBTL1
SCHEMBL22087408 0.90 ALOX5 (0.36) ALOX5CDC14BCDC14APRKDCGPR84
SCHEMBL23504496 0.90 ALOX5 (0.43) ALOX5CDC14BCDC14APRKDCTDP1
SCHEMBL23504656 0.90 CDC14B (0.41) ALOX5CDC14BCDC14ATDP1L3MBTL1
SCHEMBL25999835 0.89 ALOX5 (0.40) ALOX5CDC14BCDC14APRKDCGPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230137925-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD (JP) 2023-05-04 — — US disclosed
US-11569449-B2 Organic electroluminescence device and novel compound IDEMITSU KOSAN CO., LTD. (JP) 2023-01-31 — — US disclosed
US-20210062078-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230137925-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND DDT, DDC, ODC1 ALOX5 2721/4885CDC14B 4460/4885CDC14A 4197/4885
US-11569449-B2 Organic electroluminescence device and novel compound PIEZO1, TMEM109, OXA1L ALOX5 4031/4885CDC14B 3881/4885CDC14A 3854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback